Algert Global LLC Athenex, Inc. Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $2,841 - $6,306	-6,930 Reduced 35.81%	12,420 $5,000
Q1 2022 May 16, 2022	BUY	$0.79 - $1.59 $15,286 - $30,766	19,350 New	19,350 $16,000
Q2 2021 Aug 13, 2021	SELL	$3.71 - $5.13 $241,892 - $334,476	-65,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.08 - $14.75 $266,016 - $961,700	65,200 New	65,200 $280,000
Q4 2020 Feb 12, 2021	SELL	$11.06 - $14.01 $129,512 - $164,057	-11,710 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $120,144 - $170,380	11,710 New	11,710 $142,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.